The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.00
Bid: 142.00
Ask: 145.00
Change: 0.00 (0.00%)
Spread: 3.00 (2.113%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 142.00
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading update and COVID-19 update

3 Apr 2020 07:00

RNS Number : 6624I
Redcentric PLC
03 April 2020

Redcentric plc

("Redcentric" or the "Company")

Trading update and COVID-19 update

Redcentric plc (AIM: RCN), a leading UK IT managed services provider, is today issuing a trading update for the year ended 31 March 2020 along with an update in relation to the current impact of and measures taken by the Company in response to COVID-19.

Trading update for the year ended 31 March 2020

The Board is pleased to announce that the Company's trading performance for the year ended 31 March 2020 is expected to be in line with its expectations.

Net debt at 31 March 2020 was 拢13.5m, including 拢0.4m of share buy backs in the second half of the financial year.

The Company expects to report its full year results for the year ended 31 March 2020 on 25 June 2020.

COVID-19 update

Overview

The Company's overriding concern is the health, safety and wellbeing of its employees, customers and business partners. We are complying with all relevant government recommendations both in the UK and India and the vast majority of our staff have been working remotely since 17 March 2020. We pride ourselves in delivering excellent customer service and this has not been affected following these changes. This has been made possible by our employees' flexible and positive attitude and we thank them for their support during this time.

The duration and extent of the economic consequences of the pandemic are currently unknown and this makes predicting future demand for the Company's offerings difficult. However, the Board believes that the Company is well placed to withstand the current challenges. In particular:

Our strategy of focusing on our network and platform infrastructure has put us in a good position to meet the increased demand for flexible and remote co-working.

Our recent focus on the Public sector networks and, in particular, the Health and Social Care Networks (HSCN) has provided a large number of new logo customers where we have significant cross sell opportunities.

90% of our revenues are recurring in nature and over half of our non-recurring revenue has historically been derived from the Health sector.

The business is operating profitably with pre IFRS16 EBITDA margins expected to increase.

The business is cash generative and the recent network and platform upgrades mean that we have modern, scalable platforms which will require lower levels of capital expenditure over the medium term.

We have low levels of borrowing with pre IFRS16 net debt currently less than one times annualised pre IFRS16 EBITDA. As at 31 March 2020, gross cash was 拢3.7m with a further 拢8.0m available from undrawn bank credit facilities.

Sales

In the second half of March 2020 we saw a material increase in sales opportunities as a result of the COVID-19 pandemic. Demand has been particularly strong for increased bandwidth and, in particular, for our secure remote access product. As a result, the volume of new recurring revenue contracts signed in March was materially above that seen in previous years.

We are currently working on closing out the remaining leads generated in March and as a result we expect April new sales volumes to be as anticipated for this time of the year.聽

Looking further forward, we anticipate a reduction in sales to new customers and a slowdown in major change projects from existing customers until such time as the COVID-19 crisis is averted. We also anticipate that some of our customers may come under pressure as a result of the COVID-19 pandemic and this may lead to delayed customer receipts and increased business failures.聽

Offsetting this, we expect a lower level of normalised cancellations and renewal churn in the same period.

Deliveries

Deliveries in the last quarter of FY20 have been strong as a result of significant additional temporary resource being employed to roll out the HSCN contracts. Whilst these networks have been slower to roll out than anticipated, circa 75% of the contracts are now implemented with the remainder expected to be live by the end of June 2020.聽

The additional sales orders signed in March 2020 and those anticipated for April 2020 are all products that are very quick to install and require minimal third-party intervention.

With respect to the remaining unfulfilled orders, installations requiring on-site engineers are likely to be delayed and hence revenues will be delayed. At this time, it is impossible to know how long this situation is likely to continue.

Share buyback and dividend

The Board has taken the decision to temporarily halt the share buyback programme until such time as the outlook becomes more certain.

In addition, although the Board will continue to monitor the effects of Covid-19, in light of the current situation it is highly unlikely that a final dividend for the year will be recommended by the Board.

Enquiries:

Redcentric plc +44 (0)800 983 2522

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

finnCap Ltd - Nomad and Broker +44 (0)20 7220 0500

Marc Milmo/ Simon Hicks (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
TSTUPUAACUPUGBP
Date   Source Headline
7th Sep 20207:00 amRNSForm 8 (OPD) - Redcentric plc
4th Sep 20204:37 pmRNSForm 8.3 - Redcentric PLC
4th Sep 20209:08 amRNSForm 8.3 - Redcentric Plc
4th Sep 20208:55 amRNSForm 8.3 - Redcentric Plc
3rd Sep 20205:35 pmRNSForm 8.3 - Redcentric Plc
3rd Sep 20204:41 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
3rd Sep 20204:33 pmRNSForm 8.3 - Redcentric plc
3rd Sep 20201:15 pmRNSForm 8 (OPD) - Redcentric PLC
3rd Sep 202012:00 pmRNSForm 8.5 (EPT/RI) - Redcentric Plc
3rd Sep 20209:07 amRNSForm 8.3 - Redcentric PLC
3rd Sep 20208:30 amRNSRule 2.9 Announcement
2nd Sep 20207:00 amRNSResponse to press speculation-formal sales process
1st Sep 20208:30 amRNSRestitution Scheme Update
1st Sep 20207:00 amRNSSave As You Earn Share Option Scheme
24th Aug 202010:23 amRNSRestitution Scheme Update
17th Aug 20202:45 pmRNSRestitution Scheme Update
11th Aug 20207:00 amRNSPublication of Annual Report and Notice of AGM
11th Aug 20207:00 amRNSRestitution Scheme Update
29th Jul 20207:00 amRNSIssue of Equity and Total Voting Rights
21st Jul 20207:00 amRNSPreliminary Results Announcement FY20
13th Jul 20201:19 pmRNSGeneral Meeting Result, Voting Rights & Admission
26th Jun 202010:07 amRNSAdditional Voting Support
26th Jun 20207:00 amRNSProposed Restitution Scheme and Placing
26th Jun 20207:00 amRNSTrading Update and Results Date
19th Jun 20207:00 amRNSDelay of Full Year Results
9th Jun 20207:00 amRNSExtension of bank facilities
12th May 20203:22 pmRNSHolding(s) in Company
3rd Apr 20207:01 amRNSBoard Changes
3rd Apr 20207:00 amRNSTrading update and COVID-19 update
19th Mar 20205:48 pmRNSTransaction in Own Shares
17th Mar 20205:41 pmRNSTransaction in Own Shares
16th Mar 20205:15 pmRNSTransaction in Own Shares
27th Feb 20207:00 amRNSTransaction in Own Shares
13th Jan 20207:00 amRNSChange of Adviser
28th Nov 20197:00 amRNSHalf Year Results
20th Nov 20195:06 pmRNSTransaction in Own Shares
5th Nov 20195:02 pmRNSTransaction in Own Shares
30th Oct 20195:18 pmRNSTransaction in Own Shares
29th Oct 20197:00 amRNSTransaction in Own Shares
25th Oct 20195:23 pmRNSTransaction in Own Shares
17th Oct 20197:00 amRNSBoard Changes
9th Oct 20197:00 amRNSTrading Update
30th Sep 20197:00 amRNSDirector/PDMR Shareholding and Issue of Equity
27th Sep 20195:57 pmRNSTransaction in Own Shares
17th Sep 20197:00 amRNSShare Buyback Programme
4th Sep 20192:30 pmRNSIssue of Options
2nd Sep 20191:03 pmRNSResult of AGM
30th Aug 20194:27 pmRNSDirector Shareholding
30th Aug 20194:19 pmRNSSave As You Earn Share Option Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.